Follow Us

Screen Shot 2012-04-25 at 5.08.04 PM Screen Shot 2012-04-19 at 9.24.49 AM  

Subscribe to this blog via E-mail

Your email:

screen-shot-2012-04-19-at-91109-am

Posts by category

screen-shot-2012-04-19-at-91109-am

Current Articles | RSS Feed RSS Feed

How Online Ordering Helps Streamline Your Business

 
screen-shot-2012-04-26-at-114830-amAlmost every company struggles with inventory at one time or another. This can be a particularly difficult issue in the healthcare industry, since there are rules and regulations that monitor and structure the distribution of medical device items.

Following are three ways online ordering helps streamline your business:

  1. Increase overall cost savings: Companies that order items online are able to order smaller quantities, when necessary; comparison shop; and easily access order history.  Bottom line: online ordering allows your organization to be more nimble, with one central purchasing and ordering point to maximize time and profit. 
  2. Access to Online Database: Another way that online ordering of medical devices and products streamlines business is through an online database of vendors , which ultimately means your organization spends less time searching for the inventory you need.
  3. Reliability:  When medical inventory is sold online, much time is wasted if sellers do not note or are not upfront about damage or expiration dates. An online business that provides an inspection service can eliminate this problem by requiring inspection prior to placing the items online for sale. 
When preparing to order medical products or devices online, request information about order minimums, participation fees and shipping costs. Finding a company that makes ordering and shipping items quick and easy will further streamline the process.




New CMS Mandate: Medical Device Manufacturers Must Report on Provider Relationships

 
New CMS Mandate: Medical Device Manufacturers Must Report on Provider Relationships


As part of the Obama administration's Affordable Care Act, drug and device manufacturers will soon be required to disclose financial relationships with health care providers. Effective March 31, 2013, this rule aims to bring a higher level of transparency to the relationships between manufacturers and providers. The belief is that patients deserve to know whether their providers have financial commitments or reap financial benefits from drug or device manufacturers, since these relationships can possibly affect the care being provided.  

This rule also extends to a Group Purchasing Organization (GPO) that is able to leverage the purchasing power of hospital systems or a network of doctors' offices. For example, GPOs and medsurg distributors would be required to disclose if there are any contractual financial relationships in addition to the bulk purchases they make.  Since the GPO may then sell the supplies purchased in bulk to physician's offices or small clinics at a lower rate then market value, it is easy to understand why transparency in these relationships is vital.

There are penalties associated with improper or incomplete filing of financial relationships. The civil penalties will be capped at $150,000 for failure to report and $1,000,000 for knowingly failing to report.

Tracking the Progress of the FDA's Proposal for a Worldwide Medical Device Code

 
FDA inspection
In July 2011, a proposal for the implementation of a worldwide medical device code was submitted by the FDA, for review by the Office of Management and Budget. The initiative was first voted in by Congress in 2007, but it is awaiting full review before the FDA can take action. The code would mandate the use of a worldwide central computer database, where devices would be tracked by a uniform labeling system.

Current procedures in place for medical device tracking are inadequate and slow. Some of these devices can cause extensive health problems if they fail, such as pacemakers and artificial hip joints. The ability to quickly recall faulty batches of medical devices would considerably speed the process of locating patients who have had faulty devices implanted. This saves valuable time that can be used to remove and replace devices before they fail and cause potentially fatal problems.

One such device that was recalled in 2011 was a defibrillator implant, which had the potential to pull out of the heart and fail. Recalling the device involved tracking down hospitals that had purchased the device, then searching records to find patients that underwent implantation in the right time period. With a uniform device labeling system in place, this implant could have been recalled more completely in a less labor-intensive fashion.

A similar standard labeling system is in place for prescription drugs, easily allowing companies to reach out to patients who may have received a faulty batch. Even shoppers who purchase dog food are more likely to hear about a recall in a timely fashion than patients who have undergone major surgery with a faulty medical device. With a similar system already monitoring where prescription drugs go, it should be easy for the FDA to implement such a system for medical device monitoring once they receive approval.

Since receiving the proposal last year, the OMB (the Office of Management and Budget) has been silent on the issue. The FDA cannot take further steps toward implementing the system or even make changes that may help the proposal reach approval until they hear from the OMB about why the proposal has not been reviewed. If the proposal eventually reaches approval, the implementation of the uniform labeling system could  monitor millions of implanted devices and help notify patients of recalls in a timely manner.


Image By U.S. Department of Health and Human Services [Public domain], via Wikimedia Commons

Our MD Program, Explained

 
The Palm Tree Group's MD ProgramBy: Parker Bigley

The Palm Tree Group’s Master Distribution (MD) Program is designed to help distributors solve the cost-to-serve dilemma in the supply chain.  We understand that the distribution community is faced with incredible challenges, from cost pressures to service and margin pressures.  

The typical distributor carries anywhere from 1,200 to 2,500 manufacturers, of these manufactures, roughly 90% of the volume is generated from about 10% of the suppliers.  The remaining volume is spread across the rest of the suppliers-- an expensive proposition for the distributor.

How is The Palm Tree Group’s Master Distribution Program different?

In a word, focus.  We’re focused on the tail-end of the supply chain, as an industry-wide solution.  Many manufacturers and distributors struggle to create efficient economic partnerships when the volume to individual distribution channels is small.  By aggregating the national distributors’ volume, and having only one ship to location, the economics and partnerships improve.  The manufacturer is now part of a high-volume supply chain partnership.  Additionally, the distributor is able to rationalize suppliers without disrupting service to their customer.  It is truly a win-win-win.

The Problem

The reason there is a such a significant number of vendors is because there is not quality alignment in the supply chain.  The GPO’s and Providers contract with the manufacturers, who in turn may or may not have a relationship with the primary distributor-- who ultimately is delivering the product.  In many cases, the manufacturers’ business practices (such as electronic communications, order minimums, and product type) make it expensive or cost prohibitive to service appropriately.  This is why there is a significant delta between the agreed upon compliance in a contract and the actual compliance in a contract.

The Solution

Our MD Program improves this situation by addressing the needs of the distributor and the manufacturer.  It reduces cost across the board, and improves service levels to the end user.  

Our goal for the distributor is to decrease costs by lowering on hand inventory, reducing receipts, reducing back orders, lowering lead times, and increasing turns.  

For our manufacturing partners, we remove significant transportation and transaction costs.  We typically reduce hundreds of small orders per month to a handful of large orders.  Additionally, we communicate with our vendors and customers in whatever manner is most efficient for them, whether it’s EDI, web, phone or fax.

Bottom Line: The Palm Tree Group’s MD Program is a win-win-win for the healthcare supply chain. We create opportunity for our distributor partners to service their contracts, without filling up their storefront.  In turn, they’re able to move hard inventory dollars off their balance sheets.  The manufacturer is able to utilize our MD Program to reduce significant back office activities and redeploy personnel and build capacity in their organizations.

Want to learn more about our MD Program?  Click here.

Or, would you like to talk to someone at The Palm Tree Group?  Click here: Talk to Sales.


Tags: 

GPO's Push Toward Global Purchasing Standards: How That Effects Your Medical Inventory

 
GPOs Push Toward Global Purchasing Standards: How that Effects Your Medical Inventory

As medical distributors work to improve and enhance the delivery of medical care by providing the tools, devices, and products necessary for world class care, they have also been indispensable to the development of global purchasing standards.  These standards, created for entity locations, are crucial to reducing overall health care costs, improving supply chain efficiency, and ensuring fundamental patient safety.

A survey released in 2010, conducted by the Health Industry Group Purchasing Association (HIGPA), found that a majority of respondents were committed to the adoption of a global data standards system.  

New Medical Equipment and Technology: How it Affects Your Inventory

 
screen-shot-2012-04-10-at-120731-pm

While buying new medical supplies is a common practice for our industry, it comes with certain risks. For one, technological advances are made so quickly these days that even new equipment becomes easily outdated. As a result, you may find yourself having to spend even more just to stay current.

5 Things to Consider Before Finalizing Your Medical Equipment Purchases

 
5 Things

When you buy expensive medical equipment, you want to make sure you are getting what you want before you finalize a purchase. In particular, when it comes to overstock medical product distributors, you want one that is reliable and that offers quality equipment. Here are five things to consider before you finalize your purchases:

1) Experience and reputation: Because there is so much money at stake, it is smart to only buy equipment from medical product distributors with a solid reputation. There are few guarantees when you buy equipment at a discount, and getting involved with a disreputable firm could cost you thousands. HIDA Overstock is endorsed by the Health Industry Distributors Association, and our large client base speaks to our reputation.

2) Price: The main reason to buy overstock medical equipment is the sharp discounts that are available. When you deal with less experienced medical product distributors, you could end up paying more than you expected, when shipping costs and fees are taken into account. When you buy from HIDA Overstock, you can rest assured that what you see is what you get. There is no minimum order, no fee to participate and all orders ship freight-free. We guarantee at least a 15 percent savings. In addition, we maintain a clearance rack of heavily discounted items that are always available.

3) Safety standards: One risk associated with buying overstock is that older medical equipment might no longer comply with FDA regulations. Before you finalize a purchase, make sure the distributor has a system in place for identifying non-compliant devices. HIDA Overstock equipment is inspected to ensure that it complies with all regulations. Equipment that does not comply is set aside and not sold.

4) Usability: By the same token, purchasing used or refurbished equipment can result in worn-out devices that are no longer usable. Only reputable medical product distributors are keen to ensure that all equipment sold is in good shape. At HIDA Overstock, we only allow equipment to pass through our system that has at least one year of shelf life left on it.

5) Reliable Inventory: Medical companies want to know that they can keep returning to a single distributor for all their medical equipment needs. Because HIDA Overstock pairs buyers and sellers using proprietary software, we have a potentially limitless inventory. As a result, you can rely on a single distributor each time you need a new piece of equipment.

Overstock: Turning a Disadvantage into an Opportunity

 
Turning Overstock into Profit

Medical supply companies face many challenges in their day-to-day operations. In particular, unpredictable markets and demand can make it difficult to manage your inventory properly. You run the risk of investing too heavily in any sort of equipment, leading to unsellable overstock. In addition, technological innovations can make your existing inventory outdated in a hurry. 

Healthcare Reform 2012: What is a Taxable Medical Device?

 
screen-shot-2012-04-10-at-120731-pm

As of January 2013, according to new FDA regulations, certain medical devices will be considered taxable. The Patient Protection and Affordable Care Act in conjunction with the Health Care and Education Reconciliation Act of 2010 deemed that an excise tax would be imposed on certain items. As a result, it was deemed that a total of 2.3 percent of an item's sale price must be paid by the producer, manufacturer or importer of the taxable devices.

It's all part of the new health reform regulations listed in REG-113770-10.

Which Medical Devices Will Be Taxable?

According to the new regulations, taxable medical devices include any implement, apparatus, machine, instrument, implant, contrivance, in vitro reagent or other related or similar items. In addition, component parts and accessories are also included. Those devices defined as intended for treatment, diagnosis, cure and affecting bodily functions etc are impacted by the new regulations.

The provisions also recognize that the FDA may have missed some things in the process of categorizing relevant articles. If it becomes apparent that an item was overlooked or becomes relevant, it will be considered to be included in the taxable categories as soon as the FDA notifies the importer, manufacturer or producer that the item in question is taxable.

Any Exempted items?

Everyday items like contact lenses, eyeglasses and hearing aids that are normally purchased for private use by individuals are exempt.

How Will the New Taxes Impact Patients?

Health reform has been in consideration for some time. It is not clear how these new regulations will affect the average patient who relies on the now soon-to-be taxable devices. It would seem likely that prices could rise as a result.

Will the new regulations negatively affect patients? Will the potential rise in prices affect Medicare and other government programs that impact low income and elderly individuals? The answers to those questions and others remain to be seen.

Heathcare Reform 2012: What is Kitting and How Does It Affect Medical Device Distributors?

 
Capitol HillKitting is the packaging of diverse products (or, in some cases, services) for sale to a customer, usually a distributor, looking to present a "one stop shopping" front in a particular area of commerce.  We, in the health care industry, look to anticipate the affects of health reform laws upon the medical equipment and supply businesses.

     We have to anticipate because none of us can predict with certainty operational cost and supply consequences of the new law until it becomes fully effective later in 2012.  There are proponents and detractors at this preliminary stage and predictions from both ends of the spectrum.  Culling facts relied upon by each end and assimilating them into the highest likelihoods, some conclusions approach certainty.

  1. There will be a larger demand for medical equipment and devices because there will be a larger pool of "customers".  We will see many more people who will be eligible for health care benefits.

  2. As demand increases, we will see more products manufactured to meet the need.

  3. As more devices and pieces of equipment are manufactured, we will see distribution plans and rates which are likely to lag from area to area.  Warehousing and  overstocking will become concerns for many of these manufacturers and their distributors.

  4. Health reform will bring the inevitability of insured benefits seeking the lowest costs combining with manufacturer overstocks, we will see the need for solutions to the market and guides along the path between supply and demand.

Kitting is an excellent facilitating method.  Manufacturers and distributors carrying excess inventory will be looking to sell overstock.  These businesses will seek alternative means to normal sales representatives and methods in order to reduce oversupply and costs of warehousing. Selling in combinations with other products will arise as a significant solution system.

What if an all purpose medical supply chain experiences increased demand and distributors of diverse medical products, representing different brands from different suppliers is each overstocked?  Similarly, what if a group of hospitals experiences simultaneous increased demands for EKG's, MRI's and computerized equipment to evaluate testing? Someone can put packages together for all these differing things to meet these needs. This is kitting.

Have additional thoughts or questions?  Leave a comment below!

 

All Posts